吉格列汀(rINN)以前被鉴定为LC15-0444,是新型二肽基肽酶-4(DPP-4)抑制剂类药物的口服抗高血糖剂(抗糖尿病药物)。众所周知,DPP-4抑制剂的降糖作用主要由GLP-1和胃抑制多肽(GIP)内分泌激素介导,而胃抑制多肽(GIP)内分泌激素被DPP-4失活。

清空选项
647863-25-0 tert-Butyl 3-oxo-4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate
BD241608647863-25-095%
¥3517.001g常备现货
911634-75-8 tert-Butyl 3,3-difluoropiperidine-1-carboxylate
BD564396911634-75-898%
¥379.001g常备现货
911636-86-7 2,4-Bis(trifluoromethyl)-5,6,7,8-tetrahydropyrido-[3,4-d]pyrimidine hydrochloride
BD316091911636-86-798+%
¥29959.005g
911636-87-8 7-Boc-2,4-bis(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine
BD316092911636-87-898+%
¥24709.005g
1